Clinical Report: Comprehensive Evaluation of Cardiac, Endocrine, and Genetic Factors
Overview
This study evaluated 55 young basketball athletes for cardiac, endocrine, and genetic factors associated with tall stature. Key findings included echocardiographic abnormalities in 7% of athletes and a diagnosis of Marfan syndrome in one participant, with no endocrine dysfunctions detected.
Background
Tall stature is advantageous in basketball but can be linked to serious health risks, including cardiovascular and endocrine disorders. The potential for sudden cardiac death (SCD) is particularly concerning in this population, necessitating thorough evaluations. Current screening practices may not adequately identify underlying health issues, as noted in various studies.
Data Highlights
Finding
Percentage
Echocardiographic abnormalities
7%
Physiological adaptation findings
9%
Clinically relevant dysmorphic features
47%
Mild dysmorphia
38%
Monogenic cause of tall stature (Marfan syndrome)
1.8%
Key Findings
7% of athletes exhibited echocardiographic abnormalities.
1.8% were diagnosed with Marfan syndrome due to a pathogenic variant in the FBN1 gene.
Clinical Implications
Routine evaluations for young basketball athletes should include echocardiography and genetic testing to identify potential health risks associated with tall stature.
Conclusion
The study emphasizes the importance of comprehensive evaluations in young basketball athletes to uncover hidden health risks associated with tall stature.
Moderate coffee consumption generally appeared safe for most adults, but randomized evidence suggested divergent effects on atrial fibrillation and premature ventricular contractions.
